WSC4 Antibody

What is WASHC4 and why is it important in cellular research?

WASHC4 (WASH Complex Subunit 4) functions as a component of the WASH core complex, acting as a nucleation-promoting factor (NPF) at the surface of endosomes. It plays a critical role in recruiting and activating the Arp2/3 complex to induce actin polymerization, which is essential for the fission of tubules that serve as transport intermediates during endosome sorting . Research into WASHC4 is particularly significant because it helps elucidate fundamental mechanisms of cellular trafficking and sorting processes. The protein is also known by several synonyms including MRT43, SWIP, strumpellin and WASH-interacting protein, and KIAA1033 . Understanding WASHC4 function provides insights into cellular homeostasis and potential therapeutic interventions for related disorders.

What are the most common applications for WASHC4 antibodies in research?

WASHC4 antibodies are employed in several key research applications:

• Western Blot (WB): The most widely used application for detecting and quantifying WASHC4 protein expression in cell or tissue lysates .

• Immunohistochemistry (IHC): Used to visualize the localization of WASHC4 in tissue sections, particularly beneficial for studying its distribution in various tissue types .

• Immunocytochemistry (ICC) and Immunofluorescence (IF): Employed to examine the subcellular localization of WASHC4, particularly its endosomal positioning .

• Immunoprecipitation (IP): Used to isolate WASHC4 and its interaction partners to study protein-protein interactions within the WASH complex .

• ELISA: Applied for quantitative detection of WASHC4 in various sample types .

Each application provides unique insights into WASHC4 biology, enabling researchers to address specific research questions related to its expression, localization, and functional interactions.

How does species reactivity affect the selection of WASHC4 antibodies?

Species reactivity is a critical consideration when selecting WASHC4 antibodies for research. WASHC4 gene orthologs have been reported in multiple species including mouse, rat, bovine, frog, zebrafish, chimpanzee, and chicken . When designing experiments, researchers must carefully select antibodies that react with their specific species of interest. Some commercially available WASHC4 antibodies demonstrate cross-reactivity with human and mouse samples, while others are species-specific .

The epitope recognition region may vary between species due to sequence variations in the WASHC4 protein. This variation necessitates careful evaluation of the antibody's species reactivity profile before experimental design. For comparative studies across multiple species, researchers should either select antibodies with documented cross-reactivity or use species-specific antibodies for each experimental model to ensure data consistency and reliability.

How can I validate the specificity of a WASHC4 antibody for my research?

Validating antibody specificity is essential for producing reliable research results. For WASHC4 antibodies, implement a multi-step validation process:

• Positive and negative controls: Use cell lines or tissues known to express or lack WASHC4. Compare wild-type samples with WASHC4 knockout or knockdown samples.

• Western blot validation: Confirm that the antibody detects a band of the expected molecular weight (~136.4 kDa for canonical human WASHC4) . Look for potential detection of the reported isoforms.

• Peptide competition: Pre-incubate the antibody with the immunizing peptide before application to demonstrate binding specificity.

• Orthogonal validation: Compare results using multiple antibodies targeting different epitopes of WASHC4.

• Cross-reactivity assessment: For closely related proteins in the WASH complex, evaluate potential cross-reactivity with other family members.

• Immunoprecipitation coupled with mass spectrometry: Verify the identity of the immunoprecipitated protein as WASHC4.

This comprehensive validation approach ensures that experimental observations genuinely reflect WASHC4 biology rather than non-specific binding or cross-reactivity artifacts.

What approaches can be used to determine the binding characteristics of WASHC4 antibodies?

Understanding the binding characteristics of WASHC4 antibodies requires systematic biophysical and immunological approaches:

• Epitope mapping: Employ peptide arrays or hydrogen-deuterium exchange mass spectrometry to identify the specific epitope recognized by the antibody.

• Affinity determination: Use surface plasmon resonance (SPR) or bio-layer interferometry (BLI) to measure the binding affinity (KD) and kinetics (kon and koff) of antibody-antigen interactions.

• Binding mode analysis: Apply computational modeling approaches similar to those used in antibody-antigen interaction studies to predict and analyze binding modes . This helps identify whether the antibody recognizes a linear or conformational epitope.

• Cross-reactivity profiling: Test the antibody against a panel of related proteins to establish specificity profiles, similar to the approaches used in designing antibodies with customized specificity profiles .

• Isoform recognition: Determine whether the antibody recognizes all known WASHC4 isoforms or is isoform-specific.

These approaches collectively provide a comprehensive understanding of the antibody's binding characteristics, enabling more precise experimental design and data interpretation.

What computational models can predict WASHC4 antibody binding specificity?

Advanced computational models can help predict and enhance WASHC4 antibody binding specificity:

• Neural network-based models: Similar to those described for other antibodies, shallow dense neural networks can be trained to predict binding energies (E) for antibody-antigen interactions . These models capture the complex relationships between antibody sequence features and binding specificity.

• Mode-based selection probability models: Computational frameworks can be developed where the probability of antibody selection (p) is expressed in terms of selected and unselected binding modes (w) . For WASHC4 antibodies, this approach could help distinguish between different epitope recognition patterns.

• Deep learning discrimination models: As demonstrated with SARS-CoV-2 and influenza antibodies, deep learning can be used to distinguish between antibodies targeting different antigens based on sequence features . Similar approaches could be applied to differentiate WASHC4-specific antibodies from those targeting related proteins.

• Affinity maturation simulation: Computational models can simulate the affinity maturation pathway of antibodies, identifying potential somatic hypermutations that might enhance WASHC4 binding specificity .

These computational approaches complement experimental methods and can guide the selection or design of WASHC4 antibodies with optimal specificity profiles for specific research applications.

How should I design experiments to study WASHC4 interactions with the WASH complex?

Designing experiments to study WASHC4 interactions within the WASH complex requires a multi-faceted approach:

• Co-immunoprecipitation (Co-IP): Use WASHC4 antibodies to pull down the protein and identify interacting partners through western blotting or mass spectrometry. This approach reveals direct and indirect protein interactions within the complex.

• Proximity labeling: Employ BioID or APEX2 proximity labeling by fusing these enzymes to WASHC4 to identify proteins in close proximity within the cellular environment.

• Förster Resonance Energy Transfer (FRET): For studying dynamic interactions, use fluorescently tagged WASHC4 and potential interacting partners to measure FRET signals that indicate protein-protein proximity.

• Yeast two-hybrid screening: Identify direct binary interactions between WASHC4 and other proteins using this classical approach.

• Truncation and domain mapping: Create a series of WASHC4 truncation constructs to identify specific domains responsible for particular protein interactions within the complex.

• Cross-linking mass spectrometry (XL-MS): Apply this technique to capture transient interactions and determine interaction sites between WASHC4 and other WASH complex components.

Each of these approaches provides complementary information about WASHC4 interactions, helping to build a comprehensive understanding of its functional role within the WASH complex.

What controls are essential when using WASHC4 antibodies for immunohistochemistry?

When performing immunohistochemistry with WASHC4 antibodies, several essential controls must be included:

• Positive tissue controls: Include tissues known to express WASHC4, such as those with endosomal-rich cell types.

• Negative tissue controls: Include tissues with minimal WASHC4 expression or use WASHC4 knockout tissue sections.

• Isotype controls: Use an antibody of the same isotype but with irrelevant specificity to assess non-specific binding.

• Absorption controls: Pre-incubate the primary antibody with purified WASHC4 protein or immunizing peptide to block specific binding sites.

• Secondary antibody controls: Omit the primary antibody but include all other staining reagents to assess secondary antibody non-specific binding.

• Antigen retrieval optimization: Test multiple antigen retrieval methods, as WASHC4 detection may be sensitive to specific retrieval conditions.

• Titration series: Perform antibody titrations to determine the optimal concentration that maximizes specific signal while minimizing background.

• Multi-antibody validation: Compare staining patterns using multiple WASHC4 antibodies targeting different epitopes to confirm specificity of the observed signal.

Proper implementation of these controls ensures that the observed staining pattern truly represents WASHC4 localization rather than technical artifacts.

How can I optimize WASHC4 antibody conditions for Western blot applications?

Optimizing WASHC4 antibody conditions for Western blot requires systematic adjustment of multiple parameters:

• Sample preparation optimization:

  • Use appropriate lysis buffers containing protease inhibitors to prevent degradation

  • Adjust protein loading (typically 20-50 μg total protein) to ensure detection of WASHC4 (~136.4 kDa)

  • Include positive control lysates known to express WASHC4

• Antibody titration:

  • Test a range of primary antibody dilutions (typically starting from 1:500 to 1:5000)

  • Determine the optimal secondary antibody dilution (usually 1:2000 to 1:10000)

• Incubation conditions:

  • Compare overnight incubation at 4°C versus 1-2 hours at room temperature

  • Test different blocking reagents (5% non-fat milk, 5% BSA, or commercial blocking buffers)

• Buffer optimization:

  • Adjust salt concentration in wash buffers (typically 0.05%-0.1% Tween-20 in TBS or PBS)

  • Test different blocking buffer compositions

• Detection system selection:

  • Compare chemiluminescence, fluorescence, or colorimetric detection methods

  • For low abundance detection, consider using signal enhancement systems

• Membrane selection:

  • Compare PVDF and nitrocellulose membranes for optimal WASHC4 detection

  • Consider pore size selection (0.45 μm vs 0.2 μm) based on protein size

• Transfer optimization:

  • Adjust transfer conditions for the high molecular weight of WASHC4 (136.4 kDa)

  • Consider extended transfer times or specialized transfer systems for large proteins

Systematic optimization of these parameters ensures reliable and reproducible detection of WASHC4 protein in Western blot applications.

How should I analyze co-localization data of WASHC4 with other endosomal markers?

Analyzing co-localization data of WASHC4 with other endosomal markers requires rigorous quantitative approaches:

This systematic approach to co-localization analysis provides robust quantitative data on the spatial relationship between WASHC4 and other endosomal markers, enhancing our understanding of its functional role.

What statistical approaches are most appropriate for analyzing WASHC4 expression across different experimental conditions?

When analyzing WASHC4 expression across different experimental conditions, several statistical approaches are appropriate:

How can I integrate WASHC4 antibody data with broader proteomic and genomic datasets?

Integrating WASHC4 antibody data with broader proteomic and genomic datasets requires sophisticated computational approaches:

• Multi-omics data integration:

  • Correlate WASHC4 protein levels (from antibody-based experiments) with mRNA expression data

  • Integrate with post-translational modification datasets to understand WASHC4 regulation

  • Combine with interaction proteomics data to place WASHC4 in broader protein networks

• Pathway and network analysis:

  • Map WASHC4 and its interactors to known cellular pathways

  • Perform network analysis to identify key nodes and hubs connected to WASHC4

  • Use tools like STRING, Cytoscape, or Ingenuity Pathway Analysis for visualization

• Correlation analysis:

  • Calculate correlation coefficients between WASHC4 expression and other proteins/genes

  • Identify co-expressed genes that might function in related processes

  • Perform hierarchical clustering to identify patterns across datasets

• Machine learning approaches:

  • Apply supervised learning methods to identify features that predict WASHC4 function

  • Use unsupervised learning for pattern discovery in complex datasets

  • Implement deep learning models similar to those used in antibody specificity prediction

• Data visualization strategies:

  • Create heatmaps to visualize WASHC4 relationships with multiple genes/proteins

  • Develop interactive visualization tools for exploring complex relationships

  • Generate dimension reduction plots (PCA, t-SNE) to identify patterns

• Data repositories and sharing:

  • Upload standardized data to public repositories following FAIR principles

  • Use consistent identifiers and metadata to facilitate cross-study comparisons

This integrative approach places WASHC4 antibody-derived data in a broader biological context, enhancing its scientific impact and potential for discovery.

What are the common pitfalls when using WASHC4 antibodies and how can they be addressed?

Several common pitfalls can arise when using WASHC4 antibodies, each requiring specific troubleshooting approaches:

• High background signal:

  • Increase blocking time or concentration of blocking agent

  • Optimize antibody dilution through systematic titration

  • Extend washing steps or increase detergent concentration in wash buffers

  • Test alternative secondary antibodies with reduced cross-reactivity

• Weak or no signal:

  • Verify WASHC4 expression in your sample through alternative methods

  • Test different sample preparation methods to ensure protein preservation

  • Optimize antigen retrieval (for IHC) or membrane transfer conditions (for WB)

  • Consider using a more sensitive detection system

  • Verify antibody functionality with positive control samples

• Non-specific bands in Western blot:

  • Increase the stringency of washing conditions

  • Optimize blocking conditions to reduce non-specific binding

  • Use gradient gels for better separation of high molecular weight proteins

  • Perform peptide competition assays to identify specific bands

• Inconsistent results between experiments:

  • Standardize all experimental protocols and reagents

  • Prepare aliquots of antibodies to avoid freeze-thaw cycles

  • Include internal controls in each experiment

  • Standardize image acquisition settings across experiments

• Cross-reactivity with related proteins:

  • Verify results with multiple antibodies targeting different epitopes

  • Include appropriate knockout or knockdown controls

  • Consider using more specific monoclonal antibodies

  • Perform immunoprecipitation followed by mass spectrometry to identify all bound proteins

Addressing these pitfalls through systematic troubleshooting ensures reliable and reproducible results when using WASHC4 antibodies.

How should I assess and verify batch-to-batch variation in WASHC4 antibodies?

Assessing and verifying batch-to-batch variation in WASHC4 antibodies is crucial for experimental reproducibility:

• Initial batch comparison testing:

  • Run side-by-side Western blots with old and new antibody batches

  • Compare immunostaining patterns in parallel using standardized samples

  • Quantify signal intensity and background levels across batches

  • Analyze specificity by comparing band patterns or staining distribution

• Reference standard implementation:

  • Establish a laboratory reference standard (e.g., a well-characterized cell lysate)

  • Test each new antibody batch against this standard

  • Document and maintain a reference dataset for comparison

• Quantitative metrics for comparison:

  • Signal-to-noise ratio measurement

  • EC50 determination for titration curves

  • Limit of detection calculation

  • Western blot band intensity quantification

• Epitope validation:

  • Confirm that new batches recognize the same epitope region

  • Perform peptide competition assays with the immunizing peptide

  • Test reactivity against both native and denatured forms of WASHC4

• Documentation and record-keeping:

  • Maintain detailed records of batch numbers and performance characteristics

  • Document any observed variations between batches

  • Create batch validation protocols specific to your experimental applications

• Bridging studies for critical experiments:

  • When transitioning to a new batch during an ongoing study, perform bridging experiments

  • Analyze a subset of samples with both old and new batches

  • Apply appropriate normalization if systematic differences are observed

This systematic approach to batch validation ensures experimental consistency and facilitates troubleshooting when unexpected variations occur.

What are the most effective strategies for validating knockdown or knockout models when studying WASHC4 function?

Validating WASHC4 knockdown or knockout models requires a multi-level confirmation approach:

• Genomic validation:

  • PCR amplification and sequencing of the targeted genomic region

  • For CRISPR/Cas9 models, characterize the exact mutation(s) introduced

  • For conditional systems, verify the presence of loxP sites or other genetic modifications

• Transcript-level validation:

  • Quantitative RT-PCR to measure WASHC4 mRNA levels

  • RNA-seq to identify potential compensatory changes in related genes

  • Analysis of alternative splicing to detect truncated transcripts

• Protein-level validation:

  • Western blot using multiple WASHC4 antibodies targeting different epitopes

  • Immunofluorescence to confirm absence of WASHC4 localization

  • Mass spectrometry-based proteomics to verify protein absence and detect potential truncated forms

• Functional validation:

  • Assess endosomal morphology and function

  • Evaluate actin polymerization at endosomal membranes

  • Examine trafficking of known cargo proteins through WASHC4-dependent pathways

  • Test for impaired endosomal fission, a key function mediated by the WASH complex

• Rescue experiments:

  • Re-express wild-type WASHC4 to confirm phenotype reversibility

  • Perform domain-specific rescue experiments to map functional regions

  • Use orthologous WASHC4 to test evolutionary conservation of function

• Controls for off-target effects:

  • Use multiple siRNA/shRNA sequences or CRISPR guide RNAs

  • Include non-targeting controls in all experiments

  • For stable lines, characterize multiple independent clones

This comprehensive validation strategy ensures that observed phenotypes genuinely result from WASHC4 depletion rather than off-target effects or incomplete knockdown/knockout.